Bal Pharma Ltd Half Yearly Results

Gross Sales

155.03

148.05

176.29

162.93

159.07

Excise Duty

0

0

0

0

0

Net Sales

155.03

148.05

176.29

162.93

159.07

Other Operating Income

0

0

0

0

0

Other Income

1.59

0.61

2.55

0.3

0.69

Total Income

156.62

148.67

178.84

163.23

159.75

Total Expenditure

139.63

133.89

159.68

148.79

144.49

PBIDT

16.99

14.77

19.16

14.44

15.27

Interest

8.96

7.89

7.02

7.46

7.27

PBDT

8.03

6.88

12.14

6.98

8

Depreciation

4.87

4.91

5.12

4.95

4.53

Minority Interest Before NP

0

0

0

0

0

Tax

-1.16

1.02

-0.77

1.53

0.06

Deferred Tax

-1.62

-0.34

1.41

-0.56

1.2

Reported Profit After Tax

5.94

1.3

6.38

1.06

2.21

Minority Interest After NP

0.02

0

0.02

0.03

0.03

Net Profit after Minority Interest

5.91

1.3

6.36

1.03

2.18

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

5.91

1.3

6.36

1.03

2.18

EPS (Unit Curr.)

3.71

0.82

4.03

0.68

1.39

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

15.92

15.92

15.8

15.69

15.69

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

10.95

9.97

10.86

8.86

9.59

PBDTM(%)

-

-

-

-

-

PATM(%)

3.83

0.87

3.61

0.65

1.38